Transcendent Capital Group LLC Invests $2 Million in SPDR S&P Biotech ETF $XBI

Transcendent Capital Group LLC bought a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 19,949 shares of the exchange traded fund’s stock, valued at approximately $1,999,000.

A number of other large investors have also added to or reduced their stakes in XBI. Compass Wealth Management LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at $1,167,000. Prime Capital Investment Advisors LLC raised its stake in SPDR S&P Biotech ETF by 37.9% in the second quarter. Prime Capital Investment Advisors LLC now owns 9,939 shares of the exchange traded fund’s stock valued at $824,000 after purchasing an additional 2,729 shares in the last quarter. Altfest L J & Co. Inc. increased its holdings in shares of SPDR S&P Biotech ETF by 63.1% in the 3rd quarter. Altfest L J & Co. Inc. now owns 124,921 shares of the exchange traded fund’s stock worth $12,517,000 after buying an additional 48,326 shares during the last quarter. Brian Low Financial Group LLC bought a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter worth $668,000. Finally, AlphaCore Capital LLC raised its position in SPDR S&P Biotech ETF by 6,650.0% during the second quarter. AlphaCore Capital LLC now owns 540 shares of the exchange traded fund’s stock valued at $45,000 after purchasing an additional 532 shares in the last quarter.

SPDR S&P Biotech ETF Trading Up 2.1%

Shares of SPDR S&P Biotech ETF stock opened at $127.35 on Tuesday. The firm has a market capitalization of $8.60 billion, a PE ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 12 month low of $66.66 and a 12 month high of $132.09. The business’s 50-day moving average price is $123.93 and its 200-day moving average price is $107.67.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.